<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">BR</journal-id>
<journal-title-group>
<journal-title>Biomedical Reports</journal-title></journal-title-group>
<issn pub-type="ppub">2049-9434</issn>
<issn pub-type="epub">2049-9442</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/br.2014.304</article-id>
<article-id pub-id-type="publisher-id">br-02-05-0628</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject></subj-group></article-categories>
<title-group>
<article-title>Effect of natural flavonoids, stilbenes and caffeic acid oligomers on protein glycation</article-title></title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>SASAKI</surname><given-names>KENROH</given-names></name><xref ref-type="corresp" rid="c1-br-02-05-0628"/></contrib>
<contrib contrib-type="author">
<name><surname>CHIBA</surname><given-names>SYUKO</given-names></name></contrib>
<contrib contrib-type="author">
<name><surname>YOSHIZAKI</surname><given-names>FUMIHIKO</given-names></name></contrib>
<aff id="af1-br-02-05-0628">Tohoku Pharmaceutical University, Sendai, Miyagi 981-8558, Japan</aff></contrib-group>
<author-notes>
<corresp id="c1-br-02-05-0628">Correspondence to: Dr Kenroh Sasaki, Tohoku Pharmaceutical University, 4-1 Komatsushima 4-chome, Aoba-ku, Sendai, Miyagi 981-8558, Japan, E-mail: <email>kenrs@tohoku-pharm.ac.jp</email></corresp></author-notes>
<pub-date pub-type="ppub">
<month>9</month>
<year>2014</year></pub-date>
<pub-date pub-type="epub">
<day>25</day>
<month>06</month>
<year>2014</year></pub-date>
<volume>2</volume>
<issue>5</issue>
<fpage>628</fpage>
<lpage>632</lpage>
<history>
<date date-type="received">
<day>19</day>
<month>05</month>
<year>2014</year></date>
<date date-type="accepted">
<day>13</day>
<month>06</month>
<year>2014</year></date></history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2014, Spandidos Publications</copyright-statement>
<copyright-year>2014</copyright-year></permissions>
<abstract>
<p>The aim of the present study was to identify the inhibitory activity of natural flavonoids, stilbenes and caffeic acid oligomers on protein glycation. Antioxidant activity was evaluated using 1,1-diphenyl-2-picrylhydrazyl radical-scavenging activity. The production of 3-deoxyglucosone (3-DG) and advanced glycation end products (AGEs) by glycation reactions were determined by high-performance liquid chromatography and fluorescence, respectively. Certain flavonoids, stilbenes and caffeic acid oligomers prevented AGE production and the IC<sub>50</sub> values of the compounds were compared. These examined compounds are assumed to suppress AGE generation by inhibiting the increase in 3-DG production through a specific unknown mechanism in the early phase of the Maillard reaction, by inhibiting the generation of active oxygen in the later phase and by suppressing the progression of the reaction. Regular, daily consumption of these compounds in the form of a food or extract is expected to aid in the prevention or inhibition of non-enzymatic amino acid glycation in the living body, which is possibly associated with aging, diabetic complications, arteriosclerotic diseases and Alzheimer&#x02019;s disease, and they may also be effective agents in cosmetics promoting anti-aging.</p></abstract>
<kwd-group>
<kwd>1,1-diphenyl-2-picrylhydrazyl radical-scavensing activity</kwd>
<kwd>3-deoxyglucosone</kwd>
<kwd>advanced glycation end products production</kwd>
<kwd>flavonoid</kwd>
<kwd>stilbene</kwd>
<kwd>caffeic acid oligomer</kwd></kwd-group></article-meta></front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Advanced glycation end products (AGEs) have recently received increasing attention as substances that are directly associated with the generation and development of diabetic complications. The accumulation of AGEs has been reported to be more apparent in the elderly and those with diabetic complications, arteriosclerotic diseases and Alzheimer&#x02019;s disease (<xref rid="b1-br-02-05-0628" ref-type="bibr">1</xref>,<xref rid="b2-br-02-05-0628" ref-type="bibr">2</xref>). Numerous studies have revealed the association of AGEs with neurodegenerative diseases (<xref rid="b3-br-02-05-0628" ref-type="bibr">3</xref>&#x02013;<xref rid="b5-br-02-05-0628" ref-type="bibr">5</xref>), the growth and metastasis of malignant tumors (<xref rid="b6-br-02-05-0628" ref-type="bibr">6</xref>) and inflammatory reactions. In the process of generating AGEs, Amadori rearrangement-induced compounds generate 3-deoxyglucosone (3-DG) (<xref rid="b7-br-02-05-0628" ref-type="bibr">7</xref>). 3-DG is considered to be a significant reaction intermediate since its generation is associated with oxidative stress, it is cytotoxic (<xref rid="b8-br-02-05-0628" ref-type="bibr">8</xref>) to cancer and normal cells, and it demonstrates mutagenic properties.</p>
<p>Natural products, such as crude drugs, reportedly include organic compounds with significant antioxidant properties. Among them, flavonoid compounds from Rutaceae, such as the <italic>Citrus</italic> genus, exhibit biological activity in various fields and their antioxidant properties are well known in the prevention of chronic disease progression (<xref rid="b9-br-02-05-0628" ref-type="bibr">9</xref>). Daily consumption of flavonoids has also been reported to reduce the risk of chronic diseases, including cardiovascular diseases and cancer. In particular, polymethoxyflavone, which is a component of citrus fruits (<xref rid="b10-br-02-05-0628" ref-type="bibr">10</xref>), has been reported to reduce inflammation (<xref rid="b11-br-02-05-0628" ref-type="bibr">11</xref>) and have an antiproliferative effect on human cancer cells (<xref rid="b12-br-02-05-0628" ref-type="bibr">12</xref>).</p>
<p>Rosmarinic acid, which is a phenylpropanoid derivative, is generally present in Boraginaceae and Lamiaceae and exhibits a variety of biological activities, including significant anti-inflammatory and antioxidant effects. With regards to the mechanisms of the anti-inflammatory effect, inhibition of 5-lipoxygenase (<xref rid="b13-br-02-05-0628" ref-type="bibr">13</xref>), inhibition of histamine release from mast cells and the scavenging of superoxide radicals (also known as the antioxidant effect) (<xref rid="b14-br-02-05-0628" ref-type="bibr">14</xref>) have been reported previously.</p>
<p>The present study, based on the aforementioned, aim to examine the inhibitory effects of flavonoids, stilbenes and caffeic acid polymers, which are known as natural antioxidant substances, on non-enzymatic amino acid glycation.</p></sec>
<sec sec-type="materials|methods">
<title>Materials and methods</title>
<sec sec-type="materials">
<title>Materials</title>
<p>Nobiletin (<xref rid="b15-br-02-05-0628" ref-type="bibr">15</xref>), piceatannol (<xref rid="b16-br-02-05-0628" ref-type="bibr">16</xref>) were purified from a peel of <italic>Citrus unshiu</italic> and <italic>Callistemon rigidus,</italic> respectively. Rosmarinic acid and lithospermic acid (<xref rid="b17-br-02-05-0628" ref-type="bibr">17</xref>) were purified from <italic>Lithospermum erythrorhizon</italic>. Bovine serum albumin (BSA) and aminoguanidine (Sigma-Aldrich, St. Louis, MO, USA); baicalin, quercetin and naringin (Nacalai Tesque, Inc., Kyoto, Japan); and baicalein, kaempferol, hesperidin and hesperetin (Wako Pure Chemical Industries, Ltd., Osaka, Japan) were purchased. Lithospermic acid B and epirabdosiin were provided by Dr Tabata (Hokkaido Mitsui Chemicals, Inc., Hokkaido, Japan).</p></sec>
<sec>
<title>Measurement of 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical-scavenging activity</title>
<p>A modified version of a previous study (<xref rid="b18-br-02-05-0628" ref-type="bibr">18</xref>) was used to measure the free radical-scavenging activity of the pure compounds with DPPH. In a 96-well microplate, 100 &#x003BC;l sample at different concentrations (in absolute MeOH) was added into wells containing 100 &#x003BC;l 0.06 mM DPPH in MeOH and mixed well. The absorbance was measured at 510 nm exactly by a microplate reader (ImmunoMini NJ-2300; Biotech Co., Ltd., Tokyo, Japan) after 30 min and the percentage inhibition was calculated. IC<sub>50</sub> values express the sample concentration required to scavenge 50&#x00025; of the DPPH-free radicals. All the samples were assessed in triplicate.</p></sec>
<sec>
<title>AGE production inhibitory assay</title>
<p>The assay was carried out in accordance with a previous study (<xref rid="b19-br-02-05-0628" ref-type="bibr">19</xref>). D-Glucose (10&#x00025;) and BSA (1&#x00025;) were dissolved in phosphate-buffered saline (PBS) (pH 7.2). The samples were dissolved in PBS with 5&#x00025; DMSO. The glucose-BSA solution (900 &#x003BC;l) and sample solution (100 &#x003BC;l) were mixed under asepsis and the mixture was incubated for 22 weeks at 37&#x000B0;C with 100&#x00025; humidity. The assay samples were collected at 0, 1, 3, 5, 9 and 22 weeks. Fluorescence (F) was measured at 440 nm, excited at 375 nm, following the dilution of the mixture (1:10). The inhibitory activity was calculated as follows: Inhibitory activity (&#x00025;) = &#x0005B;1 &#x02212; (F sample &#x02212; F sample<sub>Blank</sub>)/(F control &#x02212; F normal)&#x0005D; &#x000D7; 100. For the control (F control), the PBS buffer was used instead of the sample solution in PBS. The F sample constituted the sample solution and glucose-BSA solution; F sample<sub>Blank</sub> was the sample solution without incubation; and F normal was the glucose-BSA solution without incubation. The detection of 3-DG was performed in accordance with a previous study (<xref rid="b20-br-02-05-0628" ref-type="bibr">20</xref>). Briefly, following the sample collection, 3-DG was labeled by 2,3-diaminonaphthalene for 14 h at 4&#x000B0;C, using 0.05&#x00025; 2,3-butanedione as an internal standard. The reaction mixture was analyzed by high-performance liquid chromatography (HPLC) &#x0005B;column, COSMOSIL 5PE-MS, 4.6&#x000D7;250 mm (Nacalai Tesque, Inc.); mobile phase, 50 mM phosphorus acid-CH<sub>3</sub>CN-MeOH (60:20:20), 1.0 ml/min; detector, UV at 268 nm&#x0005D; at 20&#x000B0;C.</p></sec>
<sec>
<title>Statistics</title>
<p>IC<sub>50</sub> values were expressed as the mean of triplicate experiments in DPPH-radical scavenging activity. The fluorescence values of advanced glycation-end products were expressed as the mean of triplicate experiments. The values of 3-DG formation were expressed as the mean &#x000B1; standard error of the mean. Significance was tested by assessing the effects of the compounds compared to aminoguanidine, and P&lt;0.05 was considered to indicate a statistically significant difference.</p></sec></sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title>Effects of flavonoids and caffeic acid polymers on DPPH radical-scavenging activity</title>
<p>The inhibitory effects of eight types of flavonoid, two types of stilbene and five types of caffeic acid polymer were examined on the DPPH radical-scavenging actvity. The results are shown in <xref rid="tI-br-02-05-0628" ref-type="table">Table I</xref>. The IC<sub>50</sub> of quercetin was the highest for the flavonoids, at 53.75 &#x003BC;M. Stilbenes showed stronger antioxidant effects than flavonoids; the IC<sub>50</sub> values of piceatannol and resveratrol were 46.8 and 47.16 &#x003BC;M, respectively. Among the caffeic acid polymers, lithospermic acid B exhibited the strongest inhibitory effect, followed by epirabdosiin, lithospermic acid, rosmarinic acid and caffeic acid. In particular, lithospermic acid B showed the strongest radical-scavenging effect, with an IC<sub>50</sub> of 10.26 &#x003BC;M. The IC<sub>50</sub> values of epirabdosiin and lithospermic acid were 12.38 and 34.26 &#x003BC;M, respectively, suggesting that the radical-scavenging effects are enhanced depending on the degree of polymerization.</p></sec>
<sec>
<title>Effects of flavonoids and caffeic acid polymers on the generation of 3-DG</title>
<p>Sugar-dicarbonyls, such as 3-DG, are useful markers for the effects of protein glycation inhibitors and defense mechanisms against protein glycation in the body as they show high-level reactivity. A sample was collected 20 weeks after initiating the incubation and 3-DG was derivatized in the sample with 2,3-diaminoaphthalene to examine the effect of the flavonoids, stilbenes and caffeic acid polymers using HPLC. 2,3-Butanedione was used as an internal standard. The amount of 3-DG generated by BSA (50 mg/ml) and glucose (500 &#x003BC;M) was suppressed by the addition of these compounds as compared to the control. Among the flavonoids, kaempferol and naringin showed significant differences compared to aminoguanidine (<xref rid="f1-br-02-05-0628" ref-type="fig">Fig. 1</xref>). Among the stilbenes, resveratrol and piceatannol exhibited suppressing effects that were as strong as aminoguanidine (<xref rid="f2-br-02-05-0628" ref-type="fig">Fig. 2</xref>). Among the caffeic acid polymers, lithospermic acid, lithospermic acid B and epirabdosiin showed significant differences, whereas caffeic acid and rosmarinic acid did not. The amount of 3-DG generated with lithospermic acid, lithospermic acid B and epirabdosiin was 35.84, 38.89 and 36.2 &#x003BC;g/ml, respectively, compared to 83.34 &#x003BC;g/ml with the control (<xref rid="f3-br-02-05-0628" ref-type="fig">Fig. 3</xref>).</p></sec>
<sec>
<title>Effects of the flavonoids and caffeic acid polymers on the generation of AGE-derived fluorescent materials</title>
<p>The increase of fluorescence attributed to AGE-derived fluorescent materials was examined with fluorescence spectrophotometry 1, 3, 4 and 9 weeks after the initiation of the incubation. In all the flavonoids, stilbenes and caffeic acid polymers compounds, the intensity of the fluorescence decreased compared to the control (<xref rid="f4-br-02-05-0628" ref-type="fig">Figs. 4</xref>&#x02013;<xref rid="f6-br-02-05-0628" ref-type="fig">6</xref>). Aminoguanidine, which was a positive control, inhibited the intensity of AGE-derived fluorescence by ~30&#x00025; 9 weeks after the initiation of the incubation. The amino groups of aminoguanidine bind to the keto group of an Amadori product (ketoamine) in the early phase of protein glycation and the keto group of 3-DG in the late phase, and the subsequent reactions are considered to inhibit the progression (<xref rid="b21-br-02-05-0628" ref-type="bibr">21</xref>). Baicalin, baicalein and nobiletin, which are flavonoids, inhibited the intensity of AGE-derived fluorescence by 31.4, 34.8 and 32.4&#x00025;, respectively. For the stilbenes, piceatannol showed 27.8&#x00025; inhibition, which was similar to the inhibition exhibited by aminoguanidine, and resveratrol showed 44.2&#x00025; inhibition, which was stronger compared to aminoguanidine. The inhibitory effects of the caffeic acid polymers were low compared to those of the flavonoids and stilbenes, at ~20&#x00025;.</p></sec></sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>Flavonoids, stilbenes and caffeic acid polymers all have antioxidant properties, and it is suggested that they inhibit the generation of AGEs by inhibiting oxidative stress reactions during the Maillard reaction and by suppressing the progression of these reactions in the later phases. Oxidation is not involved in the formation of Amadori rearrangement compounds, whereas oxidation is associated with the generation of AGEs, including pentosidine (<xref rid="b22-br-02-05-0628" ref-type="bibr">22</xref>) and carboxymethyllysine (<xref rid="b23-br-02-05-0628" ref-type="bibr">23</xref>), and fluorescent as well as bridged structures, which are certain AGE characteristics (<xref rid="b24-br-02-05-0628" ref-type="bibr">24</xref>). As the Amadori compounds are converted to AGEs by active oxygen, they become sources of active oxygen. Highly-reactive intermediates, including 3-DG, rapidly promote the generation of AGEs and AGEs that fluoresce by generating 3-DG, such as pentosidine and pyrropyridine, increase as the reaction progresses. The majority of the plant polyphenols used in the present study strongly suppressed 3-DG generation and, as a result, the generation of AGEs. However, AGEs are assumed to be generated through the reaction pathway for the auto-oxidation of glucose, which is not associated with 3-DG. In this pathway, highly-reactive dicarbonyl compounds, including glyoxal and methylglyoxal, react with proteins and generate AGEs (<xref rid="b25-br-02-05-0628" ref-type="bibr">25</xref>). Therefore, a clear positive correlation could not be shown between the antioxidant property and inhibition of AGE generation. These examined compounds are assumed to suppress AGE generation by inhibiting the increase of 3-DG through a specific unknown mechanism in the early phase of the Maillard reaction, by inhibiting the generation of active oxygen in the later phase and by suppressing the progression of the reaction. Further examinations are required to determine whether each compound affects both the early and late phases, or only one of them.</p>
<p>Flavonoids are oxidized by a direct reaction with free radicals, the free radicals are stabilized and the active oxygen species are directly eliminated. The possibility that these plant polyphenols directly bind to proteins (<xref rid="b26-br-02-05-0628" ref-type="bibr">26</xref>), which are substrates that would inhibit the bonding of sugars and proteins and suppress the promotion of the Maillard reaction, was also suggested. Caffeic acid polymers have a tannic effect. The interactions between tannins and proteins are associated with hydrogen bonding and hydrophobic interactions based on van der Waals forces, and the repelling of water and polymerization generally intensifies the tannic effect (<xref rid="b27-br-02-05-0628" ref-type="bibr">27</xref>). The involvement of the carboxyl group and its steric structure, as well as the degree of polymerization, have been suggested to have important roles in inhibiting the Maillard reaction.</p>
<p>These compounds are generally consumed more as multiple components rather than individually. Regular, daily consumption of these compounds in the form of a food or extract is expected to aid in the prevention or inhibition of non-enzymatic amino acid glycation in the living body, which is possibly associated with aging, diabetic complications, arteriosclerotic diseases and Alzheimer&#x02019;s disease, and they may also be effective agents in cosmetics promoting anti-aging.</p></sec></body>
<back>
<ref-list>
<title>References</title>
<ref id="b1-br-02-05-0628"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barlovic</surname><given-names>DP</given-names></name><name><surname>Soro-Paavonen</surname><given-names>A</given-names></name><name><surname>Jandeleit-Dahm</surname><given-names>KA</given-names></name></person-group><article-title>RAGE biology, atherosclerosis and diabetes</article-title><source>Clin Sci (Lond)</source><volume>121</volume><fpage>43</fpage><lpage>55</lpage><year>2011</year></element-citation></ref>
<ref id="b2-br-02-05-0628"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vitek</surname><given-names>MP</given-names></name><name><surname>Bhattacharya</surname><given-names>K</given-names></name><name><surname>Glendening</surname><given-names>JM</given-names></name><name><surname>Stopa</surname><given-names>E</given-names></name><name><surname>Vlassara</surname><given-names>H</given-names></name><name><surname>Bucala</surname><given-names>R</given-names></name><name><surname>Manogue</surname><given-names>K</given-names></name><name><surname>Cerami</surname><given-names>A</given-names></name></person-group><article-title>Advanced glycation end products contribute to amyloidosis in Alzheimer disease</article-title><source>Proc Natl Acad Sci USA</source><volume>91</volume><fpage>4766</fpage><lpage>4770</lpage><year>1994</year></element-citation></ref>
<ref id="b3-br-02-05-0628"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sasaki</surname><given-names>N</given-names></name><name><surname>Toki</surname><given-names>S</given-names></name><name><surname>Chowei</surname><given-names>H</given-names></name><name><surname>Saito</surname><given-names>T</given-names></name><name><surname>Nakano</surname><given-names>N</given-names></name><name><surname>Hayashi</surname><given-names>Y</given-names></name><name><surname>Takeuchi</surname><given-names>M</given-names></name><name><surname>Makita</surname><given-names>Z</given-names></name></person-group><article-title>Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer&#x02019;s disease</article-title><source>Brain Res</source><volume>888</volume><fpage>256</fpage><lpage>262</lpage><year>2001</year></element-citation></ref>
<ref id="b4-br-02-05-0628"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sasaki</surname><given-names>N</given-names></name><name><surname>Takeuchi</surname><given-names>M</given-names></name><name><surname>Chowei</surname><given-names>H</given-names></name><name><surname>Kikuchi</surname><given-names>S</given-names></name><name><surname>Hayashi</surname><given-names>Y</given-names></name><name><surname>Nakano</surname><given-names>N</given-names></name><name><surname>Ikeda</surname><given-names>H</given-names></name><name><surname>Yamagishi</surname><given-names>S</given-names></name><name><surname>Kitamoto</surname><given-names>T</given-names></name><name><surname>Saito</surname><given-names>T</given-names></name><name><surname>Makita</surname><given-names>Z</given-names></name></person-group><article-title>Advanced glycation end products (AGE) and their receptor (RAGE) in the brain of patients with Creutzfeldt-Jakob disease with prion plaques</article-title><source>Neurosci Lett</source><volume>326</volume><fpage>117</fpage><lpage>120</lpage><year>2002</year></element-citation></ref>
<ref id="b5-br-02-05-0628"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kikuchi</surname><given-names>S</given-names></name><name><surname>Shinpo</surname><given-names>K</given-names></name><name><surname>Ogata</surname><given-names>A</given-names></name><name><surname>Tsuji</surname><given-names>S</given-names></name><name><surname>Takeuchi</surname><given-names>M</given-names></name><name><surname>Makita</surname><given-names>Z</given-names></name><name><surname>Tashiro</surname><given-names>K</given-names></name></person-group><article-title>Detection of N epsilon-(carboxymethyl)lysine (CML) and non-CML advanced glycation end-products in the anterior horn of amyotrophic lateral sclerosis spinal cord</article-title><source>Amytroph Lateral Scler Other Motor Neuron Disord</source><volume>3</volume><fpage>63</fpage><lpage>68</lpage><year>2002</year></element-citation></ref>
<ref id="b6-br-02-05-0628"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abe</surname><given-names>R</given-names></name><name><surname>Shimizu</surname><given-names>T</given-names></name><name><surname>Sugawara</surname><given-names>H</given-names></name><name><surname>Watanabe</surname><given-names>H</given-names></name><name><surname>Nakamura</surname><given-names>H</given-names></name><name><surname>Choei</surname><given-names>H</given-names></name><name><surname>Sasaki</surname><given-names>N</given-names></name><name><surname>Yamagishi</surname><given-names>S</given-names></name><name><surname>Takeuchi</surname><given-names>M</given-names></name><name><surname>Shimizu</surname><given-names>H</given-names></name></person-group><article-title>Regulation of human melanoma growth and metastasis by AGE-AGE receptor interactions</article-title><source>J Invest Dermatol</source><volume>122</volume><fpage>461</fpage><lpage>467</lpage><year>2004</year></element-citation></ref>
<ref id="b7-br-02-05-0628"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dyer</surname><given-names>DG</given-names></name><name><surname>Blackledge</surname><given-names>JA</given-names></name><name><surname>Thorpe</surname><given-names>SR</given-names></name><name><surname>Baynes</surname><given-names>JW</given-names></name></person-group><article-title>Formation of pentosidine during nonenzymatic browning of proteins by glucose. Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo</article-title><source>J Biol Chem</source><volume>266</volume><fpage>11654</fpage><lpage>11660</lpage><year>1991</year></element-citation></ref>
<ref id="b8-br-02-05-0628"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kato</surname><given-names>H</given-names></name><name><surname>van Chyuyen</surname><given-names>N</given-names></name><name><surname>Shinoda</surname><given-names>T</given-names></name><name><surname>Sekiya</surname><given-names>F</given-names></name><name><surname>Hayase</surname><given-names>F</given-names></name></person-group><article-title>Metabolism of 3-deoxyglucosone, an intermediate compound in the Maillard reaction, administered orally or intravenously to rats</article-title><source>Biochem Biophys Acta</source><volume>1035</volume><fpage>71</fpage><lpage>76</lpage><year>1990</year></element-citation></ref>
<ref id="b9-br-02-05-0628"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rice-Evans</surname><given-names>C</given-names></name><name><surname>Spencer</surname><given-names>JP</given-names></name><name><surname>Schroeter</surname><given-names>H</given-names></name><name><surname>Rechner</surname><given-names>AR</given-names></name></person-group><article-title>Bioavailability of flavonoids and potential bioactive forms in vivo</article-title><source>Drug Metabol Drug Interact</source><volume>17</volume><fpage>291</fpage><lpage>310</lpage><year>2000</year></element-citation></ref>
<ref id="b10-br-02-05-0628"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>GJ</given-names></name><name><surname>Han</surname><given-names>SC</given-names></name><name><surname>Yi</surname><given-names>EJ</given-names></name><name><surname>Kang</surname><given-names>HK</given-names></name><name><surname>Yoo</surname><given-names>ES</given-names></name></person-group><article-title>The inhibitory effect of premature <italic>Citrus unshiu</italic> extract on atopic dermatitis in vitro and in vivo</article-title><source>Toxicol Res</source><volume>27</volume><fpage>173</fpage><lpage>180</lpage><year>2011</year></element-citation></ref>
<ref id="b11-br-02-05-0628"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baek</surname><given-names>SH</given-names></name><name><surname>Kim</surname><given-names>SM</given-names></name><name><surname>Nam</surname><given-names>D</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Ahn</surname><given-names>KS</given-names></name><name><surname>Choi</surname><given-names>SH</given-names></name><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Shim</surname><given-names>BS</given-names></name><name><surname>Chang</surname><given-names>IM</given-names></name><name><surname>Ahn</surname><given-names>KS</given-names></name></person-group><article-title>Antimetastatic effect of nobiletin through the down-regulation of CXC chemokine receptor type 4 and matrix metallopeptidase-9</article-title><source>Pharm Biol</source><volume>50</volume><fpage>1210</fpage><lpage>1218</lpage><year>2012</year></element-citation></ref>
<ref id="b12-br-02-05-0628"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manthey</surname><given-names>JA</given-names></name><name><surname>Guthrie</surname><given-names>N</given-names></name></person-group><article-title>Antiproliferative activities of citrus flavonoids against six human cancer cell lines</article-title><source>J Agric Food Chem</source><volume>50</volume><fpage>5837</fpage><lpage>5843</lpage><year>2002</year></element-citation></ref>
<ref id="b13-br-02-05-0628"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>H</given-names></name><name><surname>Sakakibara</surname><given-names>J</given-names></name><name><surname>Nagatsu</surname><given-names>A</given-names></name><name><surname>Sekiya</surname><given-names>K</given-names></name></person-group><article-title>Inhibitors of arachidonate lipoxygenase from defatted perilla seed</article-title><source>J Agric Food Chem</source><volume>46</volume><fpage>862</fpage><lpage>865</lpage><year>1998</year></element-citation></ref>
<ref id="b14-br-02-05-0628"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>Y</given-names></name><name><surname>Ohto</surname><given-names>Y</given-names></name><name><surname>Murakami</surname><given-names>A</given-names></name><name><surname>Ohigashi</surname><given-names>H</given-names></name></person-group><article-title>Inhibitory effects of curcumin and tetrahydrocurcuminoids on the tumor promoter-induced reactive oxygen species generation in leukocytes in vitro and in vivo</article-title><source>Jpn J Cancer Res</source><volume>89</volume><fpage>361</fpage><lpage>370</lpage><year>1998</year></element-citation></ref>
<ref id="b15-br-02-05-0628"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sasaki</surname><given-names>K</given-names></name><name><surname>Yoshizaki</surname><given-names>F</given-names></name></person-group><article-title>Nobiletin as a tyrosinase inhibitor from the peel of Citrus fruit</article-title><source>Biol Pharm Bull</source><volume>25</volume><fpage>806</fpage><lpage>808</lpage><year>2002</year></element-citation></ref>
<ref id="b16-br-02-05-0628"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>K</given-names></name><name><surname>Ishihara</surname><given-names>T</given-names></name><name><surname>Khono</surname><given-names>E</given-names></name><name><surname>Miyase</surname><given-names>T</given-names></name><name><surname>Yoshizaki</surname><given-names>F</given-names></name></person-group><article-title>Constituents of stem bark of <italic>Callistemon rigidus</italic> showing inhibitory effects on mouse alpha-amylase activity</article-title><source>Biol Pharm Bull</source><volume>29</volume><fpage>1275</fpage><lpage>1277</lpage><year>2006</year></element-citation></ref>
<ref id="b17-br-02-05-0628"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murata</surname><given-names>T</given-names></name><name><surname>Sasaki</surname><given-names>K</given-names></name><name><surname>Sato</surname><given-names>K</given-names></name><name><surname>Yoshizaki</surname><given-names>F</given-names></name><name><surname>Yamada</surname><given-names>H</given-names></name><name><surname>Mutoh</surname><given-names>H</given-names></name><name><surname>Umehara</surname><given-names>K</given-names></name><name><surname>Miyase</surname><given-names>T</given-names></name><name><surname>Warashina</surname><given-names>T</given-names></name><name><surname>Aoshima</surname><given-names>H</given-names></name><etal/></person-group><article-title>Matrix metalloproteinase-2 inhibitors from <italic>Clinopodium chinense</italic> var. <italic>parviflorum</italic></article-title><source>J Nat Prod</source><volume>72</volume><fpage>1379</fpage><lpage>1384</lpage><year>2009</year></element-citation></ref>
<ref id="b18-br-02-05-0628"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>SK</given-names></name><name><surname>Mbwambo</surname><given-names>ZH</given-names></name><name><surname>Chung</surname><given-names>H</given-names></name><name><surname>Luyengi</surname><given-names>L</given-names></name><name><surname>Gamez</surname><given-names>EJ</given-names></name><name><surname>Mehta</surname><given-names>RG</given-names></name><name><surname>Kinghorn</surname><given-names>AD</given-names></name><name><surname>Pezzuto</surname><given-names>JM</given-names></name></person-group><article-title>Evaluation of the antioxidant potential of natural products</article-title><source>Comb Chem High Throughput Screen</source><volume>1</volume><fpage>35</fpage><lpage>46</lpage><year>1998</year></element-citation></ref>
<ref id="b19-br-02-05-0628"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valencia</surname><given-names>JV</given-names></name><name><surname>Weldon</surname><given-names>SC</given-names></name><name><surname>Quinn</surname><given-names>D</given-names></name><name><surname>Kiers</surname><given-names>GH</given-names></name><name><surname>DeGroot</surname><given-names>J</given-names></name><name><surname>TeKoppele</surname><given-names>JM</given-names></name><name><surname>Hughes</surname><given-names>TE</given-names></name></person-group><article-title>Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics</article-title><source>Anal Biochem</source><volume>324</volume><fpage>68</fpage><lpage>78</lpage><year>2004</year></element-citation></ref>
<ref id="b20-br-02-05-0628"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamada</surname><given-names>H</given-names></name><name><surname>Miyata</surname><given-names>S</given-names></name><name><surname>Igaki</surname><given-names>N</given-names></name><name><surname>Yatabe</surname><given-names>H</given-names></name><name><surname>Miyauchi</surname><given-names>Y</given-names></name><name><surname>Ohara</surname><given-names>T</given-names></name><name><surname>Sakai</surname><given-names>M</given-names></name><name><surname>Shoda</surname><given-names>H</given-names></name><name><surname>Oimomi</surname><given-names>M</given-names></name><name><surname>Kasuga</surname><given-names>M</given-names></name></person-group><article-title>Increase in 3-deoxyglucosone levels in diabetic rat plasma. Specific in vivo determination of intermediate in advanced Maillard reaction</article-title><source>J Biol Chem</source><volume>269</volume><fpage>20275</fpage><lpage>20280</lpage><year>1994</year></element-citation></ref>
<ref id="b21-br-02-05-0628"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edelstein</surname><given-names>D</given-names></name><name><surname>Brownlee</surname><given-names>M</given-names></name></person-group><article-title>Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine</article-title><source>Diabetes</source><volume>41</volume><fpage>26</fpage><lpage>29</lpage><year>1992</year></element-citation></ref>
<ref id="b22-br-02-05-0628"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sady</surname><given-names>C</given-names></name><name><surname>Khosrof</surname><given-names>S</given-names></name><name><surname>Nagaraj</surname><given-names>R</given-names></name></person-group><article-title>Advanced Maillard reaction and crosslinking of corneal collagen in diabetes</article-title><source>Biochem Biophys Res Commun</source><volume>214</volume><fpage>793</fpage><lpage>797</lpage><year>1995</year></element-citation></ref>
<ref id="b23-br-02-05-0628"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>MU</given-names></name><name><surname>Thorpe</surname><given-names>SR</given-names></name><name><surname>Baynes</surname><given-names>JW</given-names></name></person-group><article-title>Identification of N epsilon-carboxymethyllysine as a degradation product of fructoselysine in glycated protein</article-title><source>J Biol Chem</source><volume>261</volume><fpage>4889</fpage><lpage>4894</lpage><year>1986</year></element-citation></ref>
<ref id="b24-br-02-05-0628"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reddy</surname><given-names>S</given-names></name><name><surname>Bichler</surname><given-names>J</given-names></name><name><surname>Wells-Knecht</surname><given-names>KJ</given-names></name><name><surname>Thorpe</surname><given-names>SR</given-names></name><name><surname>Baynes</surname><given-names>JW</given-names></name></person-group><article-title>N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins</article-title><source>Biochemistry</source><volume>34</volume><fpage>10872</fpage><lpage>10878</lpage><year>1995</year></element-citation></ref>
<ref id="b25-br-02-05-0628"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thornalley</surname><given-names>PJ</given-names></name><name><surname>Langborg</surname><given-names>A</given-names></name><name><surname>Minhas</surname><given-names>HS</given-names></name></person-group><article-title>Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose</article-title><source>Biochem J</source><volume>344</volume><fpage>109</fpage><lpage>116</lpage><year>1999</year></element-citation></ref>
<ref id="b26-br-02-05-0628"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>J</given-names></name><name><surname>Jin</surname><given-names>F</given-names></name><name><surname>Wu</surname><given-names>Q</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Gao</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name></person-group><article-title>Molecular interaction study of flavonoid derivative 3d with human serum albumin using multispectroscopic and molecular modeling approach</article-title><source>Talanta</source><volume>126</volume><fpage>116</fpage><lpage>121</lpage><year>2014</year></element-citation></ref>
<ref id="b27-br-02-05-0628"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richard</surname><given-names>T</given-names></name><name><surname>Lefeuvre</surname><given-names>D</given-names></name><name><surname>Descendit</surname><given-names>A</given-names></name><name><surname>Quideau</surname><given-names>S</given-names></name><name><surname>Monti</surname><given-names>JP</given-names></name></person-group><article-title>Recognition characters in peptide-polyphenol complex formation</article-title><source>Biochim Biophys Acta</source><volume>1760</volume><fpage>951</fpage><lpage>958</lpage><year>2006</year></element-citation></ref></ref-list></back>
<floats-group>
<fig id="f1-br-02-05-0628" position="float">
<label>Figure 1</label>
<caption>
<p>Effects of flavonoids on the formation of 3-deoxyglucosone (3-DG). Data are shown as mean &#x000B1; standard error of the mean (n=6). <sup>*</sup>P&lt;0.05, significantly different from the aminoguanidine value.</p></caption>
<graphic xlink:href="BR-02-05-0628-g00.gif"/></fig>
<fig id="f2-br-02-05-0628" position="float">
<label>Figure 2</label>
<caption>
<p>Effects of stilbenes on the formation of 3-deoxyglucosone (3-DG). Data are shown as mean &#x000B1; standard error of the mean (n=6).</p></caption>
<graphic xlink:href="BR-02-05-0628-g01.gif"/></fig>
<fig id="f3-br-02-05-0628" position="float">
<label>Figure 3</label>
<caption>
<p>Effects of caffeic acid derivatives on the formation of 3-deoxyglucosone (3-DG). Data are shown as mean &#x000B1; standard error of the mean (n=6). <sup>*</sup>P&lt;0.05, significantly different from the aminoguanidine value.</p></caption>
<graphic xlink:href="BR-02-05-0628-g02.gif"/></fig>
<fig id="f4-br-02-05-0628" position="float">
<label>Figure 4</label>
<caption>
<p>Inhibitory effects of flavonoids against the formation of advanced glycation-end products. Data are shown as mean (n=6).</p></caption>
<graphic xlink:href="BR-02-05-0628-g03.gif"/></fig>
<fig id="f5-br-02-05-0628" position="float">
<label>Figure 5</label>
<caption>
<p>Inhibitory effects of stilbenes against the formation of advanced glycation-end products. Data are shown as mean (n=6).</p></caption>
<graphic xlink:href="BR-02-05-0628-g04.gif"/></fig>
<fig id="f6-br-02-05-0628" position="float">
<label>Figure 6</label>
<caption>
<p>Inhibitory effects of caffeic acid derivatives against the formation of advanced glycation-end products. Data are shown as mean (n=6).</p></caption>
<graphic xlink:href="BR-02-05-0628-g05.gif"/></fig>
<table-wrap id="tI-br-02-05-0628" position="float">
<label>Table I</label>
<caption>
<p>DPPH-radical scavenging activity of plant-polyphenols<xref rid="tfn1-br-02-05-0628" ref-type="table-fn">a</xref>.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="bottom" align="left">Polyphenols</th>
<th valign="bottom" align="center">IC<sub>50</sub>, &#x003BC;M</th></tr></thead>
<tbody>
<tr>
<td valign="top" align="left">Baicalin</td>
<td valign="top" align="right">60.06</td></tr>
<tr>
<td valign="top" align="left">Baicalein</td>
<td valign="top" align="right">72.96</td></tr>
<tr>
<td valign="top" align="left">Nobiletin</td>
<td valign="top" align="right">&gt;100</td></tr>
<tr>
<td valign="top" align="left">Kaempferol</td>
<td valign="top" align="right">173.18</td></tr>
<tr>
<td valign="top" align="left">Quercetin</td>
<td valign="top" align="right">53.75</td></tr>
<tr>
<td valign="top" align="left">Naringin</td>
<td valign="top" align="right">&gt;100</td></tr>
<tr>
<td valign="top" align="left">Hesperidin</td>
<td valign="top" align="right">&gt;100</td></tr>
<tr>
<td valign="top" align="left">Hesperetin</td>
<td valign="top" align="right">&gt;100</td></tr>
<tr>
<td valign="top" align="left">Piceatannol</td>
<td valign="top" align="right">46.80</td></tr>
<tr>
<td valign="top" align="left">Resveratrol</td>
<td valign="top" align="right">47.16</td></tr>
<tr>
<td valign="top" align="left">Caffeic acid (CA)</td>
<td valign="top" align="right">93.78</td></tr>
<tr>
<td valign="top" align="left">Rosmarinic acid (RA)</td>
<td valign="top" align="right">43.68</td></tr>
<tr>
<td valign="top" align="left">Lithospermic acid (LA)</td>
<td valign="top" align="right">34.26</td></tr>
<tr>
<td valign="top" align="left">Lithospermic acid B (LAB)</td>
<td valign="top" align="right">10.26</td></tr>
<tr>
<td valign="top" align="left">Epirabdosiin (RAB)</td>
<td valign="top" align="right">12.38</td></tr></tbody></table>
<table-wrap-foot><fn id="tfn1-br-02-05-0628">
<label>a</label>
<p>Data are shown as mean (n=6).</p></fn><fn id="tfn2-br-02-05-0628">
<p>DPPH, 1,1-diphenyl-2-picrylhydrazyl.</p></fn></table-wrap-foot></table-wrap></floats-group></article>
